CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology ...
GE HealthCare GEHC recently unveiled its next-generation SIGNA MRI portfolio, the 3T SIGNA Bolt and 1.5T SIGNA Sprint with Freelium, aimed at boosting efficiency, advancing precision diagnostics and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results